Advances in management of movement disorders in children.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Lancet Neurology

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(16)00132-0PMID 27302239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gabapentin can significantly improve dystonia severity and quality of life in children.

  2016cited by this paper
• Medication use in childhood dystonia.

  2016cited by this paper
• Progression to musculoskeletal deformity in childhood dystonia.

  2016cited by this paper
• Cerebral palsy

  2016cited by this paper
• Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia

  2016cited by this paper
• Burke–Fahn–Marsden dystonia severity, Gross Motor, Manual Ability, and Communication Function Classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a ‘Rosetta Stone’ study

  2016cited by this paper
• Wilson's disease and other neurological copper disorders.

  2015cited by this paper
• Interventional studies in childhood dystonia do not address the concerns of children and their carers.

  2015cited by this paper
• Juvenile myoclonic epilepsy: A system disorder of the brain.

  2015cited by this paper
• PP12.1 – 2938: Comparison of Burke-Fahn-Marsden dystonia severity, Gross Motor, Manual Abilities and Communication Function classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a Rosetta Stone study

  2015cited by this paper
• Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.

  2015cited by this paper
• A field guide to current advances in paediatric movement disorders.

  2015cited by this paper
• Medical and surgical treatment of tremors.

  2015cited by this paper
• Therapeutic Developments for Tics and Myoclonus

  2015cited by this paper
• Tourette Syndrome: Update.

  2015cited by this paper
• Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone.

  2015cited by this paper
• Tourette syndrome deep brain stimulation: A review and updated recommendations

  2015cited by this paper
• Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia

  2015cited by this paper
• Myoclonus in childhood-onset neurogenetic disorders: The importance of early identification and treatment.

  2015cited by this paper
• Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia

  2015cited by this paper
• Treatment of Paroxysmal Dyskinesias in Children

  2015cited by this paper
• Movement Disorders in Childhood

  2015cited by this paper
• Intrathecal Baclofen therapy in Germany: Proceedings of the IAB—Interdisciplinary Working Group for Movement Disorders Consensus Meeting

  2015cited by this paper
• The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study

  2014cited by this paper
• Status dystonicus: a practice guide

  2014cited by this paper
• A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome

  2014cited by this paper
• Deferiprone in Friedreich ataxia: A 6‐Month randomized controlled trial

  2014cited by this paper
• Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome

  2014cited by this paper
• Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders

  2014cited by this paper
• Genetics in dystonia.

  2014cited by this paper
• Treatment of Lesch-Nyhan disease with S-adenosylmethionine: experience with five young Malaysians, including a girl.

  2014cited by this paper
• An Update and Review of the Treatment of Myoclonus

  2014cited by this paper
• Levodopa Does Not Improve Function in Individuals with Dystonic Cerebral Palsy

  2014cited by this paper
• Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases

  2013cited by this paper
• Psychotropic Medication Use and Polypharmacy in Children With Autism Spectrum Disorders

  2013cited by this paper
• A systematic review of interventions for children with cerebral palsy: state of the evidence

  2013cited by this paper
• Medical treatment of dystonia

  2013cited by this paper
• Treatment of Tourette Syndrome with Cannabinoids

  2013cited by this paper
• Special concerns in defining, studying, and treating dystonia in children

  2013cited by this paper
• Antiepileptic drugs and Tourette syndrome.

  2013cited by this paper
• Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome.

  2013cited by this paper
• Phenomenology and classification of dystonia: A consensus update

  2013cited by this paper
• Huntington's disease in children.

  2013cited by this paper
• Consensus Paper: Management of Degenerative Cerebellar Disorders

  2013cited by this paper
• Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology

  2013cited by this paper
• Surgical treatment of myoclonus dystonia syndrome

  2013cited by this paper
• Treatment of Myoclonus

  2013cited by this paper
• Dystonia Severity Action Plan: a simple grading system for medical severity of status dystonicus and life‐threatening dystonia

  2013cited by this paper
• Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.

  2013cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.

  2013cited by this paper
• Effects of deep brain stimulation in dyskinetic cerebral palsy: A meta‐analysis

  2013cited by this paper
• The treatment of dystonic tremor: a systematic review

  2013cited by this paper
• Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia

  2013cited by this paper
• Current controversies on the role of behavior therapy in Tourette syndrome

  2013cited by this paper
• History, applications, and mechanisms of deep brain stimulation.

  2013cited by this paper
• Movement Disorder in Ataxia-Telangiectasia

  2013cited by this paper
• Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

  2013cited by this paper
• Systematic review: Pharmacological treatment of tic disorders – Efficacy of antipsychotic and alpha-2 adrenergic agonist agents

  2013cited by this paper
• Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

  2012cited by this paper
• Movement disorders in autoimmune diseases

  2012cited by this paper
• Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2012cited by this paper
• Alternating Hemiplegia of Childhood in Chinese Following Long-Term Treatment With Flunarizine or Topiramate

  2012cited by this paper
• Autoimmune Basal Ganglia Disorders

  2012cited by this paper
• Treatment for dystonia in childhood

  2012cited by this paper
• Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

  2012cited by this paper
• Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease

  2012cited by this paper
• Acute Ataxia in Children: Approach to Clinical Presentation and Role of Additional Investigations

  2012cited by this paper
• Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

  2012cited by this paper
• Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.

  2012cited by this paper
• Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months

  2012cited by this paper
• A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia

  2012cited by this paper
• Video game–based coordinative training improves ataxia in children with degenerative ataxia

  2012cited by this paper
• Treatment of Sydenham Chorea With Intravenous Immunoglobulin

  2012cited by this paper
• Gene Therapy for Aromatic l-Amino Acid Decarboxylase Deficiency

  2012cited by this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation

  2011cited by this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

  2011cited by this paper
• Treatment of patients with essential tremor.

  2011cited by this paper
• Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia

  2011cited by this paper
• The contribution of spasticity to the movement disorder of cerebral palsy using pathway analysis: does spasticity matter?

  2011cited by this paper
• Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration

  2011cited by this paper
• Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

  2011cited by this paper
• Iron‐related MRI images in patients with pantothenate kinase–associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial

  2011cited by this paper
• Deep brain stimulation in children: experience and technical pearls.

  2011cited by this paper
• A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

  2011cited by this paper
• CAG repeat size in the normal HTT allele and age of onset in Huntington's disease

  2011cited by this paper
• Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).

  2011cited by this paper
• Trihexyphenidyl Improves Motor Function in Children with Dystonic Cerebral Palsy: A Retrospective Analysis

  2011cited by this paper
• Evidence-based guideline update: Treatment of essential tremor

  2011cited by this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment Veit RoessnerKerstin J. PlessenAribert RothenbergerAndrea G. Ludolph • Renata RizzoLiselotte SkovGerd StrandJeremy S. SternCristiano Termine • Pieter J. Hoekstrathe ESSTS Guidelines Group

  2011cited by this paper
• Pharmacotherapeutics of Tourette syndrome and stereotypies in autism.

  2010cited by this paper
• Management of patients with myoclonus: available therapies and the need for an evidence-based approach.

  2010cited by this paper
• The prevalence of neuropsychiatric disorders in Sydenham's chorea.

  2010cited by this paper
• Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes

  2010cited by this paper
• Pallidal and thalamic deep brain stimulation in myoclonus‐dystonia

  2010cited by this paper
• Advances in the Pharmacological Management of Huntington’s Disease

  2010cited by this paper
• Definition and classification of hyperkinetic movements in childhood

  2010cited by this paper
• The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

  2010cited by this paper
• Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation

  2010cited by this paper
• The clinical approach to movement disorders

  2010cited by this paper
• Treatment of hyperkinetic movement disorders.

  2009cited by this paper

• French virtual multidisciplinary team meeting for pediatric movement disorders (PMD-vMDT): a three-year survey

  2026cites this paper
• Effects of Pallidal Deep Brain Stimulation on Speech and Swallowing in Pediatric Patients with Dystonia.

  2025cites this paper
• Nonmotor Symptom Scales in Children With Movement Disorders: A Scoping Review.

  2025cites this paper
• Surgical Complications of Deep Brain Stimulation in Children Across Targets and Indications: Multicenter Analysis of the CHILD-DBS Registry.

  2025cites this paper
• Effectiveness and safety of subthalamic nucleus deep brain stimulation in isolated generalised or segmental dystonia (SUNDYS trial): a study protocol.

  2025cites this paper
• Deep brain stimulation for dystonia treatment in cerebral palsy: efficacy exploration

  2025cites this paper
• Tackling Tone in Tiny Tots: Hypertonia Management in Young Children.

  2025cites this paper
• Outpatient Management of Clinical Comorbidities in Children With Cerebral Palsy in Low- and Middle-Income Countries.

  2025cites this paper
• Towards new perspectives: International consensus guidance on dystonia in pediatric palliative care.

  2025cites this paper
• Transitional Care for Young People with Movement Disorders: Consensus‐Based Recommendations from the MDS Task Force on Pediatrics

  2023cites this paper
• NeuroAI-Driven Advanced Deep Brain Stimulation for Precision Management of Movement Disorders

  2023cites this paper
• Efficacy and safety of medical cannabinoids in children with cerebral palsy: a systematic review

  2023cites this paper
• Neuroimaging-based analysis of DBS outcome in pediatric dystonia: Insights from the GEPESTIM registry

  2023cites this paper
• Investigative and Usability Findings of the Move-D Orthotic Brace Prototype for Upper Extremity Tremors in Pediatric Patients: An Unblinded, Experimental Study

  2023cites this paper
• Globus pallidus internus activity increases during voluntary movement in children with dystonia

  2023cites this paper
• Long‐Term Follow‐Up of Pediatric Patients with Dyskinetic Cerebral Palsy and Deep Brain Stimulation

  2023cites this paper
• Neuroimaging-based analysis of DBS outcomes in pediatric dystonia: Insights from the GEPESTIM registry

  2023cites this paper
• Harnessing cognitive strategy use for functional problems and proposed underlying mechanisms in childhood-onset dystonia.

  2022cites this paper
• Transition Services for Children and Young Adults with Movement Disorders: A Survey by the MDS Task Force on Pediatrics

  2022cites this paper
• Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia

  2022cites this paper
• Combined effect of orthotic intervention and conventional exercise training on balance and gait performance in cerebral palsy: a randomized controlled trial

  2022cites this paper
• Therapeutic Effects of Medicinal Cannabinoids on the Gastrointestinal System in Pediatric Patients: A Systematic Review

  2022cites this paper
• Dystonia in children with acquired brain injury.

  2022cites this paper
• Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe

  2021cites this paper
• Rehabilitation in childhood-onset hyperkinetic movement disorders including dystonia: Treatment change in outcomes across the ICF and feasibility of outcomes for full trial evaluation.

  2021cites this paper
• Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases

  2021cites this paper
• Combined Genome, Transcriptome and Metabolome Analysis in the Diagnosis of Childhood Cerebellar Ataxia

  2021cites this paper
• Recent advances in understanding hereditary spastic paraplegias and emerging therapies

  2021cites this paper
• Evaluation of the effectiveness of early intervention methods in newborns who have suffered hypoxic-ischemic CNS damage

  2021cites this paper
• Quality of Life After Deep Brain Stimulation of Pediatric Patients with Dyskinetic Cerebral Palsy: A Prospective, Single‐Arm, Multicenter Study with a Subsequent Randomized Double‐Blind Crossover (STIM‐CP)

  2021cites this paper
• Deep Brain Stimulation for Generalized Dystonia from Secondary Carnitine Deficiency: A Case Report and Literature Review.

  2021cites this paper
• Deep Brain Stimulation for Generalized Dystonia from Secondary Carnitine De ciency: A Case Report and Literature Review

  2021cites this paper
• Mental health and behaviour in children with dystonia: Anxiety, challenging behaviour and the relationship to pain and self-esteem.

  2021cites this paper
• Alpha-2 Adrenergic Medications

  2020cites this paper
• Deep Brain Stimulation for Pediatric Dystonia

  2020cites this paper
• Child Neurology: A young child with an undiagnosed case of dystonia responsive to l-dopa

  2020cites this paper
• Principles of Medical and Surgical Treatment of Cerebral Palsy.

  2020cites this paper
• Neuromodulation in Childhood Onset Dystonia: Evolving Role of Deep Brain Stimulation

  2020cites this paper
• The body communicates: Movement synchrony during music therapy with children diagnosed with ASD

  2020cites this paper
• Deep brain stimulation reduces pain in children with dystonia, including in dyskinetic cerebral palsy

  2020cites this paper
• Fifteen-minute consultation: Approach to investigation and management of childhood dystonia

  2020cites this paper
• Pharmacological Treatment of Tics

  2020cites this paper
• A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders

  2020cites this paper
• Second-Generation Anti-dopaminergic Medications

  2020cites this paper
• First-Generation Anti-dopaminergic Medications

  2020cites this paper
• Guidelines Based on Systematic Literature Review and Meta-analysis

  2020cites this paper
• Evaluation and Differential Diagnosis of Tics and Related Disorders

  2020cites this paper
• Assessment of Tic Severity

  2020cites this paper
• Other Tic-Suppressing Medications

  2020cites this paper
• Introduction: The Long and Winding Road to Tourette Syndrome

  2020cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• Guidelines Based on Expert Survey and Consensus

  2020cites this paper
• Index

  2020cites this paper
• Further reading

  2020cites this paper
• Paediatric deep brain stimulation

  2019cites this paper
• Moving forward in childhood-onset movement disorders: a multidisciplinary approach to diagnosis and care

  2019cites this paper
• Current therapies and therapeutic decision making for childhood‐onset movement disorders

  2019cites this paper
• Cognitive approach to rehabilitation in children with hyperkinetic movement disorders post-DBS

  2019influential citation
• Adverse events associated with deep brain stimulation in patients with childhood-onset dystonia.

  2019cites this paper
• Mitochondrial Symptomatic Treatments

  2019cites this paper
• Movement Disorders in Childhood Thalamic Tumors

  2018cites this paper
• Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders

  2018cites this paper
• Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.

  2018cites this paper
• Current behavioral assessments of movement disorders in children

  2018cites this paper
• Protocol for N-of-1 trials proof of concept for rehabilitation of childhood-onset dystonia: Study 1

  2018cites this paper
• Protocol for N-of-1 trials with replications across therapists for childhood-onset dystonia rehabilitation: Study 2

  2018cites this paper
• Why orthotic devices could be of help in the management of Movement Disorders in the young

  2018cites this paper
• Genetic landscape of pediatric movement disorders and management implications

  2018cites this paper
• Tailor the pharmacological management of childhood dystonia to meet the needs of each child

  2018cites this paper
• The child with dystonia

  2018cites this paper
• Tailor the pharmacological management of childhood dystonia to meet the needs of each child

  2018cites this paper
• Management of Pediatric Movement Disorders: Present and Future.

  2018cites this paper
• Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review

  2018cites this paper
• Deep brain stimulation for childhood dystonia: current evidence and emerging practice

  2018cites this paper
• Deep brain stimulation in Tourette's syndrome: new insights.

  2017cites this paper
• Clinical pearls and scientific advancement

  2017cites this paper
• Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders.

  2017cites this paper
• Safety and efficacy of high-dose enteral, intravenous, and transdermal clonidine for the acute management of severe intractable childhood dystonia and status dystonicus: An illustrative case-series.

  2017cites this paper
• Clonidine use in the outpatient management of severe secondary dystonia.

  2017cites this paper
• A comparative historical and demographic study of the neuromodulation management techniques of deep brain stimulation for dystonia and cochlear implantation for sensorineural deafness in children.

  2017cites this paper
• Managing status dystonicus outside the intensive care setting: Time to think clonidine?

  2017cites this paper
• Clinical Management of Dystonia in Childhood

  2017cites this paper
• Deep brain stimulation in cerebral palsy: Challenges and opportunities.

  2017cites this paper
• The International Classification of Functioning (ICF) to evaluate deep brain stimulation neuromodulation in childhood dystonia-hyperkinesia informs future clinical & research priorities in a multidisciplinary model of care.

  2017influential citation
• Stable cognitive functioning with improved perceptual reasoning in children with dyskinetic cerebral palsy and other secondary dystonias after deep brain stimulation.

  2017cites this paper
• What parents think and feel about deep brain stimulation in paediatric secondary dystonia including cerebral palsy: A qualitative study of parental decision-making.

  2017cites this paper
• Ataxia‐telangiectasia: recommendations for multidisciplinary treatment

  2017cites this paper
• Advances in pharmacotherapies for movement disorders in children: current limitations and future progress

  2017cites this paper
• l-Dopa in dystonia

  2017cites this paper
• Principles and approaches to the treatment of immune-mediated movement disorders.

  2017cites this paper
• Clinical presentation and management of dyskinetic cerebral palsy.

  2017cites this paper
• Management of movement disorders in children.

  2016cites this paper
• Omega-3 fatty acids and SUDEP prevention.

  2016cites this paper
• Addressing Ataxia Among Children with Cerebellar Disorders

  2016cites this paper
• Recognizing the Common Origins of Dystonia and the Development of Human Movement: A Manifesto of Unmet Needs in Isolated Childhood Dystonias

  2016cites this paper
• Management of movement disorders in children - Authors' reply.

  2016cites this paper